Xeltis scored €45 million for its restorative, bioresorbable, polymer-based heart valve replacement technology.
The deal will see Roche work with Inotrem to develop an assay for measuring a biomarker correlated to negative outcomes in septic shock patients.
Takeda and Portal will develop a needle-free system for the delivery of Takeda's drug for Crohn's and ulcerative colitis.
The 18-month study will assess whether Vectra DA delivers better outcomes and lower costs than conventional approaches.
Intuitive Surgical is dipping a toe into diagnostics—a new study showed its flexible robotics platform was used safely to take lung tissue samples.
PathAI, which teamed up with Philips on cancer diagnostics in March, has bagged $11 million in series A financing.
Medtronic has posted a look at data on the first 50 patients treated with its transcatheter mitral valve replacement (TMVR) system.
The deal will see Thermo Fisher validate and seek approval for a test to identify RET fusions in non-small cell lung cancer patients.
The U.S. DOD is putting up the money to give the army a better way of assessing moderate to severe traumatic brain injuries in combat situations.
Gecko Biomedical’s first product may be a surgical sealant, but it has eyes on much more. The sealant's polymer has many potential applications.